Drug profile · INN
botulinum toxin type b
NEUROBLOC
botulinum toxin type b (NEUROBLOC) is a vesicle-associated membrane protein 2 inhibitor. Current US regulatory status: approved.
Drug details — botulinum toxin type b
- US status
- approved
- Class
- Musculo-skeletal system (M03)
- Route
- —
- Patents
- 1
- Programs
- 7
- Data quality
- 0.83
Quick answer
botulinum toxin type b (NEUROBLOC) is a vesicle-associated membrane protein 2 inhibitor. Current US regulatory status: approved.
Key facts
Mechanism of action
Vesicle-associated membrane protein 2 inhibitor
Primary target: Vesicle-associated membrane protein 2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is botulinum toxin type b?
botulinum toxin type b (NEUROBLOC) is a vesicle-associated membrane protein 2 inhibitor. Current US regulatory status: approved.
What is the brand name for botulinum toxin type b?
NEUROBLOC is a marketed brand name for botulinum toxin type b. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of botulinum toxin type b?
botulinum toxin type b has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.